ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

No Cancer Letter For Two Weeks

August 10, 1990

In Brief DCCP Directorship Draws 100 Names; Upon Agrees Centers Programs Needs More Staff

January 13, 1978

Course On Human Research Protections Goes Online @ Cancer.Gov.

January 26, 2001

Cancer Centers Could Form Network for Genetics Research, NCI Says

April 12, 1996

In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor

January 6, 1989

DeVita Heads U.S. Board Of CCCR

August 4, 1989